mRNA, vaccine

New mRNA Vaccine Against World's Biggest Infectious Killer Shows Promise
A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently approved vaccine for TB – which recently surpassed COVID-19 to once again become the deadliest infectious disease on Earth – the findings are a great step forward in the quest to combat humanity’s ancient foe.
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
New mRNA vaccine tested in mice has potential to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading Australian research institutions.
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.
Groundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
Vaccine shows promise for pancreatic cancer, study finds
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
Trial shows promise of mRNA vaccines in treating pancreatic cancer
A recent study found that mRNA-based vaccines may help to delay the recurrence of pancreatic cancer by generating long-lasting immune responses. The phase 1 trial results, published Feb. 19 in Nature,
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
Medpage Today on MSN1d
Researchers Describe Rare Syndrome After COVID Vaccine
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
Bill to ban mRNA vaccines passes out of House committee
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
Franklin County wants health district to stop offering COVID vaccines
An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Montana seeks to ban mRNA shots as vaccine hesitancy soars
Health Secretary Robert F. Kennedy Jr. is a noted vaccine skeptic, and President Donald Trump has expressed concerns about ...
mRNA research explores new frontiers in celiac disease treatment
Jax Bari, an 11-year-old from Philadelphia, shows me a photo of himself. It's hard to look at; in it, he's sprawled out on ...